Exclusive

Publication

Byline

Location

US Patent Issued to MINORYX THERAPEUTICS on July 7 for "Method of administering a therapeutically effective amount of 5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-ylethoxyphenylmethyl-1,3-thiazolidine-2,4-dione" (Spanish, British Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,048, issued on July 7, was assigned to MINORYX THERAPEUTICS S.L. (Mataro Barcelona, Spain). "Method of administering a therapeutically effec... Read More


US Patent Issued to SHANGHAI WD PHARMACEUTICAL on July 7 for "Pharmaceutical composition containing dabigatran etexilate and preparation method thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,049, issued on July 7, was assigned to SHANGHAI WD PHARMACEUTICAL Co. LTD (Shanghai). "Pharmaceutical composition containing dabigatran etex... Read More


US Patent Issued to CENTESSA PHARMACEUTICALS (UK) on July 7 for "Compositions and their use for the treatment of A1-antitrypsin deficiency" (British Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,050, issued on July 7, was assigned to CENTESSA PHARMACEUTICALS (UK) Ltd. (Altrincham, Great Britain). "Compositions and their use for the t... Read More


US Patent Issued to SHENZHEN FIRST UNION TECHNOLOGY, SHENZHEN HERUI BIOTECHNOLOGY on July 7 for "Composition and product thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,051, issued on July 7, was assigned to SHENZHEN FIRST UNION TECHNOLOGY Co. LTD. (Shenzhen City, China) and SHENZHEN HERUI BIOTECHNOLOGY Co. L... Read More


US Patent Issued to Exelixis on July 7 for "Combinations for the treatment of cancer" (California Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,052, issued on July 7, was assigned to Exelixis Inc. (Alameda, Calif.). "Combinations for the treatment of cancer" was invented by Gisela Sc... Read More


US Patent Issued to 60 Degrees Pharmaceuticals on July 7 for "Methods for the treatment and prevention of lung infections caused by SARS-CoV-2 virus by administration of tafenoquine" (District Of Columbia Inventor)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,053, issued on July 7, was assigned to 60 Degrees Pharmaceuticals Inc. (Washington). "Methods for the treatment and prevention of lung infec... Read More


US Patent Issued to Lupin on July 7 for "Substituted nucleoside analogs as PRMT5 inhibitors" (Indian Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,054, issued on July 7, was assigned to Lupin Ltd. (Maharastra Mumbai, India). "Substituted nucleoside analogs as PRMT5 inhibitors" was inven... Read More


US Patent Issued to Vanda Pharmaceuticals on July 7 for "Treatment of atopic dermatitis with tradipitant" (Maryland Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,055, issued on July 7, was assigned to Vanda Pharmaceuticals Inc. (Washington). "Treatment of atopic dermatitis with tradipitant" was invent... Read More


US Patent Issued to Gulch Pharma on July 7 for "Oral formulation comprising a crystalline form of rabeximod" (Swedish Inventor)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,056, issued on July 7, was assigned to Gulch Pharma AB (Sollentuna, Sweden). "Oral formulation comprising a crystalline form of rabeximod" w... Read More


US Patent Issued to Cedars-Sinai Medical Center on July 7 for "RIPK2 inhibition for the treatment of cancer" (California Inventor)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,057, issued on July 7, was assigned to Cedars-Sinai Medical Center (Los Angeles). "RIPK2 inhibition for the treatment of cancer" was invente... Read More